申请人:Janssen Pharmaceutica N.V.
公开号:US05674866A1
公开(公告)日:1997-10-07
The present invention is concerned with novel imidazoazepines of formula ##STR1## the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; --A--B-- is a radical of formula --X--CH.dbd.CH-- (a-1); --CH.dbd.CH--X-- (a-2); or --CH.dbd.CH-- CH.dbd.CH-- (a-3); X represents O, S or NR.sup.1 ; R.sup.1 represents hydrogen or C.sub.1-6 alkyl; -----Y is a radical of formula .dbd.O (b-1); --OH (b-2); or .dbd.N--OH (b-3); and L represents hydrogen, C.sub.1-4 alkylcarbonyl, C.sub.1-4 alkyloxycarbonyl, phenylcarbonyl, C.sub.1-6 alkyl or C.sub.1-6 alkyl substituted with C.sub.1-4 alkyloxycarbonyl, hydroxycarbonyl, aryl, aryloxy or a radical of formula ##STR2## --D--Z-- is --S--CH.dbd.CH--, --S--CH.sub.2 --CH.sub.2 --, --S--CH.sub.2 --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 --; and aryl is phenyl or phenyl substituted with halo, hydroxy or C.sub.1-4 alkyloxy. Compositions comprising said compounds, processes for preparing the same and the use of these compounds for treating allergic diseases.
本发明涉及公式##STR1##的新型咪唑噻二唑,其药学上可接受的加成盐和立体化学异构体,其中每个虚线独立地表示可选的键;--A--B--是公式--X--CH.dbd.CH--(a-1)的基团;--CH.dbd.CH--X--(a-2);或--CH.dbd.CH-- CH.dbd.CH--(a-3);X表示O,S或NR.sup.1;R.sup.1表示氢或C.sub.1-6烷基;-----Y是公式.dbd.O(b-1)的基团;--OH(b-2);或.dbd.N--OH(b-3);L表示氢,C.sub.1-4烷基羰基,C.sub.1-4烷氧羰基,苯基羰基,C.sub.1-6烷基或C.sub.1-6烷基取代C.sub.1-4烷氧羰基,羟基羰基,芳基,芳氧基或公式##STR2##的基团;--D--Z--是--S--CH.dbd.CH--,--S--CH.sub.2--CH.sub.2--,--S--CH.sub.2--CH.sub.2--CH.sub.2--,--CH.dbd.CH--CH.dbd.CH--或--CH.sub.2--CH.sub.2--CH.sub.2--CH.sub.2--;芳基是苯基或取代卤素,羟基或C.sub.1-4烷氧基的苯基。包含这些化合物的组合物,制备这些化合物的方法以及使用这些化合物治疗过敏性疾病。